Skip to main content
SHANDONG POLYMER BIOCHEMICALS CO.,LTD. logo

SHANDONG POLYMER BIOCHEMICALS CO.,LTD. — Investor Relations & Filings

Ticker · 002476 ISIN · CNE100000TN8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,509 across all filing types
Latest filing 2026-05-20 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 002476

About SHANDONG POLYMER BIOCHEMICALS CO.,LTD.

https://www.slcapam.com

Shandong Polymer Biochemicals Co., Ltd. specializes in the research, development, and manufacturing of water-soluble polymers, with a primary focus on polyacrylamide (PAM) derivatives. The product range encompasses anionic, cationic, and non-ionic polyacrylamide, alongside super absorbent polymers (SAP). These products serve critical functions in water treatment for municipal and industrial wastewater, enhanced oil recovery (EOR) and drilling fluid additives in the energy sector, and retention and drainage aids in paper production. The company also supplies specialized polymers for mineral processing and agricultural soil management. By leveraging advanced polymerization technologies, the firm provides chemical solutions designed to optimize flocculation, sedimentation, and rheological control in various industrial processes.

Recent filings

Filing Released Lang Actions
北京中银(成都)律师事务所关于山东宝莫生物化工股份有限公司2025年度股东会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 85% confidence The document is a legal opinion letter from a law firm regarding the company’s 2025 annual general meeting, reviewing the convening procedures and then providing detailed vote counts and results for each proposal. This is not the annual report itself nor an investor presentation, but an official announcement of shareholder vote results at the AGM. It best fits the “Declaration of Voting Results & Voting Rights Announcements” category (DVA).
2026-05-20 Chinese
关于完成补选公司第七届董事会非独立董事的公告
Board/Management Information Classification · 89% confidence The document is an official announcement by the company’s board about the completion of the by-election of a non-independent director, including details of nomination, shareholder approval, and the new director’s tenure. This is a disclosure of changes in the company’s board composition, fitting the definition of Board/Management Information.
2026-05-20 Chinese
2025年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of the resolutions and voting results from the 2025 Annual General Meeting, detailing attendance, vote counts for each proposal, and legal opinions. It does not present the full annual report or financial data, but provides official voting outcomes. This matches the Definition for “Declaration of Voting Results & Voting Rights Announcements” (Code: DVA).
2026-05-20 Chinese
投资者活动记录表
Regulatory Filings Classification · 85% confidence The document is a standardized ‘Investor Relations Activity Record’ (投资者活动记录表) required by the exchange, detailing the format, date, participants and Q&A of an IR event (业绩说明会). It contains no actual financial statements or slide decks but serves as a regulatory compliance notice of an IR meeting. This does not constitute an earnings release, annual or interim report, nor a management/analyst presentation per se. It best fits the “Regulatory Filings” category for miscellaneous compliance announcements (RNS).
2026-05-15 Chinese
关于使用闲置自有资金购买银行结构性存款到期赎回并继续购买的进展公告
Regulatory Filings Classification · 80% confidence The document is a Shanghai Stock Exchange–style corporate announcement detailing the progress of the company’s use of idle internal funds to purchase, redeem, and reinvest in bank structured deposit products. It is not a financial report (10-K, IR, etc.), nor an earnings release, M&A, or board change. It is a routine compliance/regulatory disclosure with substantive details and tables on investment products. This does not fit into specific categories like share issuance, capital raising (CAP), or interest rate notices. It is therefore classified under the generic “Regulatory Filings” fallback category (RNS).
2026-05-13 Chinese
关于董事长代行董事会秘书职责的公告
Board/Management Information Classification · 93% confidence The document is an announcement by 山东宝莫生物化工股份有限公司’s board regarding a change in the appointment of the company’s board secretary (a senior management role). It details the resignation of the former secretary, the interim assignment to the general manager, and now the chairman acting as secretary until a new appointment. This falls under a Board/Management Information filing (MANG).
2026-05-12 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.